CardiAI™ is a leading-edge developer of Point of care medical diagnostic technologies. We are developing platform technologies that will transform healthcare worldwide. CardiAI™ prioritizes patient-centric care by communicating and emphasizing patient needs to their health care and information providers. CardiAI™ has a very tenacious R&D team with the capabilities ranging from biomedical engineers, electrochemical engineers, molecular biologists, business development professionals, project managers, clinical managers and clinical trial specialists.The company has developed an electrochemical biosensing based technology platform which it is using to develop Point of Care rapid diagnostic tests for Covid-19, Heart failure, and metabolic disorders (such as diabetes) etc. Using AI and machine learning approaches to monitor patient parameters, CardiAI™ anticipates to improve quality of life and reduce healthcare cost.
CoviLamp™ is Rapid Detection Kit (Real-Time Loop Mediated Isothermal Amplification test) intended for the qualitative detection of SARS-CoV-2 in upper and lower respiratory specimens. Results are delivered in as low as 30-40 minutes.